World

Elon Musk Highlights New Appetite Inhibiting Drugs As Solution To US Obesity Crisis

Elon Musk has suggested that emerging appetite-inhibiting medications could significantly address the rising obesity rates in the United States.

Obesity rates will plummet with new appetite-inhibiting drugs, says Musk

Responding to a user’s comment about the alarming obesity statistics on social media platform X, Musk expressed optimism about new pharmaceutical interventions.

“40 percent of Americans are obese,” the user pointed out, referencing data from the Organisation for Economic Co-operation and Development (OECD) from 2018.

Musk’s response was unequivocal, “They will plummet with the new appetite-inhibiting drugs.”

Obesity, a condition marked by excessive body fat, poses serious health risks and contributes significantly to the nation’s healthcare burden.

The US Centers for Disease Control and Prevention (CDC) reports that more than 40% of American adults are classified as obese.

The World Health Organization (WHO) however defines obesity as a body mass index (BMI) of 30 or higher and considers a BMI of 25 and above as overweight.

The condition can lead to severe health issues, including diabetes, hypertension, and various cancers.

Globally, obesity is a growing concern.

In 2022, the WHO estimated that 1 in 8 people worldwide lived with obesity, with over 390 million children and adolescents aged 5-9 years being overweight, including 160 million classified as obese.

Recent advancements in weight management have seen the introduction of Semaglutide, a drug marketed as Ozempic and Wegovy by Novo Nordisk.

Developers initially created Semaglutide for type 2 diabetes and later repurposed it for weight loss.

The drug mimics the hormone glucagon-like peptide 1 (GLP-1), which is naturally released after eating.

By activating GLP-1 receptors, Semaglutide reduces appetite and promotes feelings of fullness.

In 2023, Musk revealed that he lost approximately 20 pounds using Wegovy combined with intermittent fasting, which involves eating within restricted time windows.

This drug offers an alternative to more invasive weight loss surgeries and has shown promise in managing obesity.

Also Read: India, US Forge Security Of Supply Agreement To Strengthen Defense Cooperation

Mankrit Kaur

Recent Posts

JNU Suspends MoU With Turkish University Over National Security Concerns

Jawaharlal Nehru University (JNU) has suspended its academic Memorandum of Understanding (MoU) with Inonu University…

7 hours ago

Home Minister Amit Shah Lauds Security Forces For Eliminating 31 Maoists

Shah reaffirmed the government’s aim to make India Maoist-free by 31 March 2026. He said…

7 hours ago

EaseMyTrip CEO Warns Of National Security Risk From Chinese Travel Apps

The screenshots shared by Nishant Pitti revealed that Indian armed forces personnel are booking discounted…

7 hours ago

Defence Stocks Surge Over Rs 86,000 Crore In Market Value Since Pahalgam Attack

This surge followed Operation Sindoor, a large-scale, tri-service precision strike by the Indian armed forces…

8 hours ago

Yogi Adityanath Flags Off ‘Bharat Shaurya Tiranga Yatra’, Slams Pakistan As Terror Haven

“When 140 crore Indians put the nation first, no power in the world can match…

9 hours ago

78th Cannes Film Festival Opens With Tarantino, Tributes And Protests Against Trump’s Cinema Tariffs

Leonardo DiCaprio honoured legendary actor Robert De Niro with the Honorary Palme d’Or. The festival…

10 hours ago